IL129482A0 - Method of enhancing the delivery of growth factors - Google Patents

Method of enhancing the delivery of growth factors

Info

Publication number
IL129482A0
IL129482A0 IL12948297A IL12948297A IL129482A0 IL 129482 A0 IL129482 A0 IL 129482A0 IL 12948297 A IL12948297 A IL 12948297A IL 12948297 A IL12948297 A IL 12948297A IL 129482 A0 IL129482 A0 IL 129482A0
Authority
IL
Israel
Prior art keywords
enhancing
delivery
growth factors
diffusion
enhanced
Prior art date
Application number
IL12948297A
Other languages
English (en)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL129482A0 publication Critical patent/IL129482A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
IL12948297A 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors IL129482A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2856696P 1996-10-16 1996-10-16
PCT/US1997/014536 WO1998016242A1 (en) 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors

Publications (1)

Publication Number Publication Date
IL129482A0 true IL129482A0 (en) 2000-02-29

Family

ID=21844162

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12948297A IL129482A0 (en) 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors

Country Status (8)

Country Link
EP (1) EP0938333B1 (de)
JP (1) JP2001502323A (de)
AT (1) ATE258804T1 (de)
AU (1) AU733394B2 (de)
CA (1) CA2269075A1 (de)
DE (1) DE69727491T2 (de)
IL (1) IL129482A0 (de)
WO (1) WO1998016242A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524402A (ja) * 1998-09-03 2002-08-06 ニューロンズ・リミテッド 神経保護
FR2793684B1 (fr) * 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US7112570B2 (en) 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
GB0303362D0 (en) * 2003-02-13 2003-03-19 Enact Pharma Plc Tissue regeneration
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct
GB202303495D0 (en) * 2023-03-09 2023-04-26 Ucl Business Ltd Therapy for charcot-marie-tooth disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
PT101051A (pt) * 1991-11-12 1994-02-28 Regeneron Pharma Uso de nt-3, de anticorpo neutralizante anti-nt-3 e de molecula de ribozima ou anti-sentido no fabrico de um medicamento para o tratamento de desordens do sistema nervoso e processo de analise relacionados com nt-3
WO1994021282A1 (en) * 1993-03-19 1994-09-29 Immunex Corporation Pharmaceutical compositions comprising a ligand complexed with a soluble receptor

Also Published As

Publication number Publication date
EP0938333B1 (de) 2004-02-04
DE69727491D1 (de) 2004-03-11
EP0938333A1 (de) 1999-09-01
CA2269075A1 (en) 1998-04-23
WO1998016242A1 (en) 1998-04-23
ATE258804T1 (de) 2004-02-15
AU733394B2 (en) 2001-05-10
JP2001502323A (ja) 2001-02-20
DE69727491T2 (de) 2004-12-02
AU4073797A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
EP1264604A3 (de) Verbesserungen in oder an Kontrastmitteln
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
CA2267456A1 (en) Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
ATE197549T1 (de) Methoden zur regulation der den magen und darm betreffenden motilitaet
AP9801392A0 (en) Concentrated antibody preparation.
AU2693395A (en) Glial mitogenic factors, their preparation and use
ATE140483T1 (de) Natürlicher killerzellen-stimulationsfaktor
GR3032673T3 (en) Use of an effective quantitiy of active substances for the treatment of mixed skin.
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
MX9600164A (es) Composicion para la tincion por oxidacion de las fibras queratinicas y proceso de tincion que usa esta composicion.
HUP9900654A3 (en) Preparations stimulating nail growth, process for their preparation and use of them
ATE183774T1 (de) Löslicher interferon-rezeptor, seine herstellung und anwendung
MX9806082A (es) Preparacion farmaceutica combinada de analogos de lhrh y antiestrogenos para el tratamiento de trastornos ginecologicos.
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
IL129482A0 (en) Method of enhancing the delivery of growth factors
EE200000333A (et) Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod
WO1996015758A3 (en) Methods for stimulating erythropoiesis using thrombopoietin
WO1990013643A3 (en) Glycoprotein hormone receptor molecules
GB9506796D0 (en) Device
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
ES2183890T3 (es) Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
RU96111557A (ru) Способ лечения нейросенсорной тугоухости
MXPA01006011A (es) Composicion para tratamiento de quemaduras.
DE60037402D1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng